The Predictive Role of NLR, d-NLR, MLR, and SIRI in COVID-19 Mortality

Author:

Citu Cosmin,Gorun FlorinORCID,Motoc Andrei,Sas Ioan,Gorun Oana MariaORCID,Burlea Bogdan,Tuta-Sas IoanaORCID,Tomescu Larisa,Neamtu Radu,Malita Daniel,Citu Ioana Mihaela

Abstract

(1) Background: Since its discovery, COVID-19 has caused more than 256 million cases, with a cumulative death toll of more than 5.1 million, worldwide. Early identification of patients at high risk of mortality is of great importance in saving the lives of COVID-19 patients. The study aims to assess the utility of various inflammatory markers in predicting mortality among hospitalized patients with COVID-19. (2) Methods: A retrospective observational study was conducted among 108 patients with laboratory-confirmed COVID-19 hospitalized between 1 May 2021 and 31 October 2021 at Municipal Emergency Clinical Hospital of Timisoara, Romania. Blood cell counts at admission were used to obtain NLR, dNLR, MLR, PLR, SII, and SIRI. The association of inflammatory index and mortality was assessed via Kaplan–Maier curves univariate Cox regression and binominal logistic regression. (3) Results: The median age was 63.31 ± 14.83, the rate of in-hospital death being 15.7%. The optimal cutoff for NLR, dNLR, MLR, and SIRI was 9.1, 9.6, 0.69, and 2.2. AUC for PLR and SII had no statistically significant discriminatory value. The binary logistic regression identified elevated NLR (aOR = 4.14), dNLR (aOR = 14.09), and MLR (aOR = 3.29), as independent factors for poor clinical outcome of COVID-19. (4) Conclusions: NLR, dNLR, MLR have significant predictive value in COVID-19 mortality.

Publisher

MDPI AG

Subject

Clinical Biochemistry

Reference40 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. Naming the Coronavirus Disease (COVID-19) and the Virus That Causes Ithttps://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it

3. WHO Declares COVID-19 a Pandemic;Cucinotta;Acta Bio Med. Atenei Parm.,2020

4. Weekly Epidemiological Update on COVID-19—23 November 2021https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---23-november-2021

5. Coronavirus Pandemic (COVID-19)https://ourworldindata.org/coronavirus

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3